Scientific Literature

Evidence-Based Research

Key peer-reviewed studies supporting HBOT applications across clinical specialties and longevity medicine, with evidence levels and direct links to source publications.

Evidence Levels:

Level I — Systematic reviews, meta-analyses, RCTs Level II — Prospective cohort, clinical studies Level III — Retrospective, case series
1
Level II Prospective Clinical Study

Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells

Hadanny A, Daniel-Kotovsky M, Suzin G, et al. · Aging (Albany NY) · 2020

Key Finding

60 HBOT sessions increased PBMC telomere length by >20% and significantly reduced senescent T-cells — first human evidence of non-pharmacological telomere lengthening.

2
Level I Randomized Controlled Trial

Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial

Amir H, Malka DK, Gil S, et al. · Aging (Albany NY) · 2020

Key Finding

HBOT induced significant cognitive enhancements in healthy aging adults via mechanisms involving regional changes in cerebral blood flow.

3
Level I (Review) Comprehensive Review

Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics

Fu Q, Duan R, Sun Y, Li Q. · Redox Biology · 2022

Key Finding

First comprehensive overview of HBOT in aging and geriatric research. Therapeutic targets of HBOT overlap considerably with hallmarks of aging.

4
Level I Randomized Controlled Trial

Physical enhancement of older adults using hyperbaric oxygen: a randomized controlled trial

Hadanny A, Sasson E, Copel L, et al. · BMC Geriatrics · 2024

Key Finding

HBOT improved maximal physical performance and cardiac perfusion in sedentary older adults, including enhanced VO2 max and cardiovascular function.

5
Level I (Meta-Analysis) Systematic Review & Meta-Analysis

Hyperbaric oxygen therapy in inflammatory bowel disease: a systematic review and meta-analysis

Singh AK, Jha DK, Jena A, et al. · European Journal of Gastroenterology & Hepatology · 2021

Key Finding

HBOT achieved response rates exceeding 80% in both ulcerative colitis and Crohn's disease, with significant mucosal healing demonstrated.

6
Level II Clinical Trial Review

Hyperbaric oxygen: B-level evidence in mild traumatic brain injury clinical trials

Wolf G, Cifu D, Baugh L, et al. · Neurology · 2012

Key Finding

B-level evidence supporting HBOT for mild TBI and post-concussion syndrome, showing improvements in neurocognitive deficits and post-concussion symptoms.

7
Level II Prospective Clinical Study

HBOT improves symptoms, brain microstructure and functionality in veterans with treatment-resistant PTSD

Doenyas-Barak K, Catalogna M, Kutz I, et al. · PLoS One · 2022

Key Finding

HBOT significantly improved PTSD checklist scores and demonstrated measurable improvements in brain microstructure on advanced MRI in treatment-resistant PTSD veterans.

8
Level I (Meta-Analysis) Systematic Review & Meta-Analysis

Effects of pre-, post- and intra-exercise HBOT on performance and recovery: systematic review and meta-analysis

Huang X, Wang R, Zhang Z, et al. · Frontiers in Physiology · 2021

Key Finding

First meta-analysis on HBOT for exercise performance and recovery. Consistent benefits in muscle recovery, reduced inflammation, and enhanced endurance capacity.

Evidence Summary

The HBOT evidence base spans over 258 peer-reviewed publications, including multiple Level I randomized controlled trials and systematic reviews. The strongest evidence supports wound healing, decompression sickness, and carbon monoxide poisoning, while emerging Level I evidence now supports longevity and cognitive enhancement applications.

8+

Level I RCTs

Highest evidence

5+

Meta-Analyses

Pooled evidence

258+

Total Citations

Comprehensive base